Genentech, Roche, Giredestrant, Everolimus, evERA, Phase III, Breast Cancer, ER-Positive Breast Cancer, HER2-Negative, ESR1 Mutation, ESR1-Mutated Breast Cancer,

SOUTH SAN FRANCISCO, Calif. — September 30, 2026 Genentech, a member of the Roche Group, announced detailed results from...